Läkemedel

Obesity Medication Prices Dropping: Access vs. Cost Controversy

by

The pharmaceutical market for obesity treatment is undergoing significant shifts as manufacturers adjust pricing strategies in response to heightened competition and evolving healthcare policy. In Sweden, the cost of certain GLP-1 receptor agonists used for weight management has seen downward pressure, a move that highlights the ongoing tension between pharmaceutical innovation, public health accessibility, and … Read more

Common Painkiller Could Reduce Cancer Risk by 50%

by

A common, low-cost medication found in many home medicine cabinets may significantly reduce the risk of cancer returning for a specific group of patients. New findings from a large-scale Scandinavian clinical trial indicate that low-dose aspirin can halve the rate of recurrence in patients with colorectal cancer who possess specific genetic mutations. The results, stemming … Read more

GLP-1 Drugs & Weight Loss: Why Many Patients Stop Treatment

by

2026-02-23 00:09:00 Avbryter sin behandling ”Kliniska studier visar en viktminskning på 15 till 21 procent med GLP 1 läkemedel, men denna analys tyder på att resultaten i verkligheten är avsevärt lägre”, heter det i analysen. En förklaring är att många patienter avbryter behandlingen i förtid. Upp till 70 procent avslutar medicineringen inom det första året. … Read more

ADHD Medication: Who Should Avoid It & Treatment Guide

by

The use of medication to manage Attention-Deficit/Hyperactivity Disorder (ADHD) is a complex topic, often sparking debate about appropriate use, potential risks, and long-term effects. Whereas ADHD medications can be highly effective for many, they are not a one-size-fits-all solution, and careful consideration must be given to individual circumstances. Experts emphasize that medication isn’t always necessary, … Read more